Summit's data layer maps the entire patient acquisition funnel — from first intent signal through verified fulfillment — across the largest exclusive condition-confirmed cohort in healthcare.
Pharma brands spend over $30 billion annually on patient acquisition and DTC media in the United States. That spend flows through a fragmented ecosystem of vendors — data providers, identity vendors, clean rooms, lead gen platforms, landing page hosts, DSPs, attribution tools — each charging margins of 50–85% to bridge the last mile between a media impression and a converted patient.
The reason the margins are sustainable: no single vendor owns the full stack. Each layer is necessary, none of them are sufficient, and brands pay each one separately.
Exclusive data layer · proprietary identity protocol · in-house unbranded sponsor capability · full-stack campaign infrastructure.
Licensing Summit's data isn't buying records. It's skipping the part where you spend 10 years and tens of millions of dollars trying to build them yourself.
The 15.3M record count is the headline. What makes the data exclusive is what's inside each record.
Each use case maps to a specific tier combination and campaign pattern. Summit configures the mix per the brand's commercial objective.
Summit's data isn't only a targeting asset — it's a media-spend multiplier. Every campaign that starts with Summit's audience costs less to run and converts more of what it touches.
Summit isn't a vendor relationship that adds friction. It's a platform that compresses time, cost, and operational complexity.
Today, pharma brands stitch together 5–7 vendor relationships per major campaign. Summit replaces all of them with one integrated platform.
Summit Audience Segments works with brands, agencies, holding companies, and strategic partners across the full range of commercial structures. The right next step depends on what you're building.